Target intelligence / Profile preview

Eukaryotic translation initiation factor 2-alpha kinase family (EIF2AK1, EIF2AK2, EIF2AK4) (EIF2AK family)

Target
EIF2AK family
Molecular classification
Enzyme, Serine/threonine protein kinase, Eukaryotic translation initiation factor 2-alpha kinase family
01

Overview

The Eukaryotic translation initiation factor 2-alpha kinase (EIF2AK) family members EIF2AK1 (HRI), EIF2AK2 (PKR), and EIF2AK4 (GCN2) are essential regulators of the Integrated Stress Response (ISR) (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116144/; Frontiers in Cell and Developmental Biology, https://www.frontiersin.org/articles/10.3389/fcell.2020.00167). These kinases function as sensors for distinct cellular stressors: EIF2AK1 responds to heme deficiency and oxidative stress, EIF2AK2 is activated by viral double-stranded RNA, and EIF2AK4 senses amino acid starvation via uncharged tRNAs (Reactome, https://reactome.org/content/detail/R-HSA-380953; Wikipedia, https://en.wikipedia.org/wiki/EIF2AK4). Upon activation, they phosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) at Ser51, which attenuates global protein synthesis while selectively enhancing the translation of stress-adaptive mRNAs like ATF4 (UniProt, https://www.uniprot.org/uniprot/Q9BQI3; Abcam, https://www.abcam.com/pathways/integrated-stress-response). This pathway is frequently co-opted by cancer cells to survive metabolic stress and is implicated in the progression of neurodegenerative diseases, viral infections, and pulmonary veno-occlusive disease (GeneCards, https://www.genecards.org/cgi-bin/carddisp.pl?gene=EIF2AK4; BioRxiv, https://www.biorxiv.org/content/10.1101/2024.04.23.590745v1). Pharmacological modulators, including small-molecule inhibitors like GCN2iB and PKR inhibitors, are being developed to either disrupt tumor adaptation or restore translational homeostasis in chronic disease states (GlobalData, https://www.pharmaceutical-technology.com/data-insights/eif-2-alpha-kinase-gcn2-eif2ak4-pipeline-analysis-and-market-forecast/).

Other names
Heme-regulated inhibitor (HRI)Protein kinase R (PKR)General control nonderepressible 2 (GCN2)EIF2AK1EIF2AK2EIF2AK4Heme-controlled repressor (HCR)Eukaryotic translation initiation factor 2-alpha kinase 1Eukaryotic translation initiation factor 2-alpha kinase 2Eukaryotic translation initiation factor 2-alpha kinase 4
02

Mechanism of action

Inhibition of eIF2α phosphorylation to modulate the integrated stress response (ISR), thereby restoring global protein synthesis or inducing apoptosis in stressed cells (Frontiers in Oncology, https://www.frontiersin.org/articles/10.3389/fonc.2021.654398; Nature Communications, https://www.nature.com/articles/s41467-023-40823-8).

03

Biological functions

Signal transductionIntegrated stress responseTranslation regulationApoptosisImmune responseMetabolic sensing
04

Disease associations

CancerNeurodegenerative diseaseInfectionHematological disorderPulmonary veno-occlusive diseaseMetabolic disease
05

Safety considerations

Pancreatic toxicityImmunosuppressionMetabolic disruptionCompensatory activation of other ISR kinases
06

Interacting drugs

ISRIB

6 more in the full profile.

07

Biomarkers

Phospho-eIF2α (p-eIF2α)ATF4 expressionCHOP (DDIT3) levels

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2-alpha kinase family (EIF2AK1, EIF2AK2, EIF2AK4) (EIF2AK family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2-alpha kinase family (EIF2AK1, EIF2AK2, EIF2AK4) (EIF2AK family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call